Abraxane and blood sodium decreased Patient Reports February 11, 2012
Abraxane Side Effects Report #5023726-8
Abraxane side effect was reported by a Physician from UNITED STATES on Mar 14, 2006. Male patient, 83 years of age, weighting 127.0 lb, was diagnosed with non-small cell lung cancer and was treated with Abraxane. After drug was administered, patient experienced the following side effects: asthenia, azotaemia, blood chloride decreased, blood sodium decreased, chronic obstructive pulmonary disease, condition aggravated, dehydration, dysphagia, epistaxis. Abraxane dosage: 462 MG EVERY 3 WEEKS; OFF STUDY. During the same period patient was treated with CARBOPLATIN, AVASTIN, CRESTOR, TOPROL, ASPIRIN. Patient was hospitalized. Patient died on 03/17/2006.
Abraxane Side Effects Report #5976510-2
Abraxane side effect was reported by a Health Professional from CANADA on Nov 11, 2008. Male patient, 63 years of age, was diagnosed with head and neck cancer
and was treated with Abraxane. After drug was administered, patient experienced the following side effects: blood sodium decreased, catheter related complication, diarrhoea, febrile neutropenia, haemoglobin decreased, heart rate increased, hypokalaemia, thrombocytopenia, venous thrombosis limb. Abraxane dosage: 118 MG. During the same period patient was treated with CISPLATIN, FLUOROURACIL, ACETAMINOPHEN, MOUTHWASH. Patient was hospitalized. Patient recovered.Abraxane Side Effects Report #5210413-6
Abraxane side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 16, 2007. Female patient, 56 years of age, was diagnosed with fallopian tube cancer and was treated with Abraxane. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, asthenia, blood chloride decreased, blood sodium decreased, body temperature increased, dyspnoea, oedema peripheral, pneumonia
, respiratory rate increased. Abraxane dosage: 193.0 MG@100MG/M2 D1,D8, D15 042. During the same period patient was treated with CARBOPLATIN, ROBITUSSIN, HUMALOG, TRANDATE, IMODIUM, ATIVAN, MILK OF MAGNESIA, TYLENOL. Patient was hospitalized. Patient recovered.Abraxane Side Effects Report #6009136-5
Abraxane side effect was reported by a Physician from UNITED STATES on Dec 04, 2008. Female patient, 62 years of age, weighting 310.0 lb, was diagnosed with breast cancer metastatic, hypertension and was treated with Abraxane. After drug was administered, patient experienced the following side effects: arthralgia, blood bilirubin increased, blood calcium decreased, blood pressure diastolic decreased, blood sodium decreased, carbon dioxide decreased, constipation
, dehydration, haematocrit decreased. Abraxane dosage: (125 MG/M2, 9 WEEK). During the same period patient was treated with NEXAVAR, HYDROCHLOROTHIAZIDE, MOBIC, VISTERIL, LORTAB, VITAMIN, CALCIUM. Patient was hospitalized. Patient recovered.Abraxane Side Effects Report #6094812-9
Abraxane side effect was reported by a Physician from UNITED STATES on Feb 10, 2009. Female patient, 62 years of age, weighting 310.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: arthralgia, aspartate aminotransferase increased, bacteraemia, blood bilirubin increased, blood calcium decreased, blood pressure diastolic decreased, blood sodium decreased, constipation
, dehydration. Abraxane dosage: 125 MG/M2, 9 WEEK. During the same period patient was treated with NEXAVAR, HYDROCHLOROTHIAZIDE, MOBIC, VISTERIL, LORTAB, VITAMIN, CALCIUM, FLEXERIL. Patient was hospitalized. Patient recovered.Abraxane Side Effects Report #5664768-9
Abraxane side effect was reported by a Physician from UNITED STATES on Feb 26, 2008. Female patient, 61 years of age, weighting 187.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: blood sodium decreased, colitis ischaemic, endotoxic shock, metastases to lung, neutropenia, pneumonia
, renal failure acute, septic shock. Abraxane dosage: LAST DOSE (200 MG) PRIOR TO SAE ON 05-FEB-2008 (CYCLE 5) (WEEKLY, 3WKS ON THEN 1 WK. OFF), INTRAVENO. During the same period patient was treated with KYTRIL, DECADRON, TOPROL, ACIPHEX, LASIX, GABAPENTIN, CYMBALTA, ZAROXOLYN. Patient was hospitalized. Patient recovered.Abraxane Side Effects Report #5761834-4
Abraxane side effect was reported by a Physician from UNITED STATES on May 19, 2008. Female patient, 55 years of age, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alopecia, blood albumin decreased, blood glucose increased, blood sodium decreased, blood urea decreased, carbon dioxide decreased, conjunctival irritation, dermatitis, dermatitis allergic. Abraxane dosage: LAST DOSE (300 MG) PRIOR TO SAE. (120 MG/M2,WEEKLY), ,INTRAVENOUS. During the same period patient was treated with AVASTIN. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5085090-8
Abraxane side effect was reported by a Physician from UNITED STATES on Aug 02, 2006. Female patient, 48 years of age, weighting 118.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood creatinine decreased, blood sodium decreased, blood urea decreased, cholangitis acute, cholelithiasis, cholestasis, chronic obstructive pulmonary disease, haematocrit decreased. Abraxane dosage: unknown. During the same period patient was treated with AVASTIN, NEXIUM, RISPERDAL, BENADRYL, DECADRON, ZANTAC, ALOXI, OXYCONTIN. Patient recovered.
Abraxane and blood sodium decreased 